Skip to main content
Caplight Logo









Impli

Impli

Private
LondonHealthcare & Life Scienceshttps://www.impli.co/

Last Round

Grant

Jun 18, 2026

Total Funding Raised

$3.18M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Impli is a health technology company that develops implantable biosensors for real-time hormone monitoring to improve personalized care in fertility treatments and other medical applications.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Precision Medicine, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

continuous hormone monitoringbiosensorwearable health techIVF monitoringprecision medicinedigital healthimplantable sensorremote patient monitoringRPMaptamer-based sensingmicroneedle patchfemtechhealth IoTmedical devicebiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Impli Comparables

Compare Impli with similar companies based on industry and business-model similarity.

Impli comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Level Zero Health
88%
Nutromics
82%
Adaptyx Biosciences
74%

Impli Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 18, 2026
SeedJan 15, 2026
Pre SeedSep 27, 2024

Impli Investors

Notable investors and investment history

Impli investors
InvestorRounds
National Institute for Health and Care ResearchGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    $1.85M grant from the National Institute for Health and Care Research.

  • Jan 15, 2026

    $130K raised in Seed round.

Impli Filings

Explore SEC and related filing metadata, where available.

Impli filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Impli's valuation, stock price, and market status.

Is Impli a public or private company?

Impli is a private company.

What is the current stock price of Impli?

Impli is a private company with no public stock price. No recent secondary market data is available.

How much is Impli worth (valuation)?

Valuation information for Impli is not publicly available.

Can I buy Impli stock?

Impli shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Impli's last funding round?

Impli's most recent funding round was Grant on June 18, 2026.

Who are the main investors in Impli?

Key investors in Impli include National Institute for Health and Care Research.

Will Impli IPO soon?

No public IPO plans have been announced for Impli.

How can I track Impli secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Impli's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLondon
Year Founded2019
Last FundingJun 18, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?